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SAFETY AND EFFICACY OF 
VIDEO-ASSISTED THORACIC 
SURGICAL TECHNIQUES 
FOR THE TREATMENT 
OF SPONTANEOUS 
PNEUMOTHORAX 
Video-assisted thoracic surgery has been widely used in the treatment of spontane- 
ous pneumothorax despite a paucity of data regarding the relative safety and 
long-term efficacy for this procedure. We reviewed 113 consecutive patients (68 male 
and 45 female patients, aged 15 to 92 years, mean 35.1) who underwent 121 
video-assisted thoracic surgical procedures during 119 hospitalizations from 1991 
through 1993. Recurrent ipsilateral pneumothorax was the most frequent indication 
for surgery and occurred in 77 patients (65%). The most common method of 
management was stapling of an identified bleb in the lung, which was undertaken i
105 (87%) patients. No operative deaths occurred. Complications included an air 
leak lasting longer than 5 days in 10 (8%) patients, two of whom required second 
procedures for definitive management. No episodes of postoperative bleeding or 
empyema occurred. The postoperative stay ranged from 1 day to 39 days (median 3 
days, average 4.3 days) and 99 patients (84%) were discharged within 5 days. Mean 
follow-up was 13.1 months and ranged from 1 to 34 months. Eleven patients (10%) 
were lost to follow-up. Ipsilateral pneumothorax recurred after five of 121 proce- 
dures (4.1%). TWelve perioperative parameters (age, gender, race, smoking history, 
site of pneumothorax, severity O f pneumothorax, operative indications, number of 
blebs, site of blebs, bleb ablation, method of pleurodesis, and prolonged postoper- 
ative air leak) were entered into univariate and multivariate analysis to identify 
significant independent predictors of recurrence. The only independent predictor of 
recurrence was the failure to identify and ablate a bleb at operation, which resulted 
in a 23% recurrence rate versus a 1.8% rate in those with ablated blebs (p < 0.001). 
These data suggest hat video-assisted thoracic surgery is a viable alternative to 
thoracotomy for the treatment of recurrent spontaneous pneumothorax. It results in 
a short hospital stay, low morbidity, high patient acceptance, and a low rate of 
recurrence. (J THORAC CARDIOVASC SURG 1995;109:1198-204) 
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(VATS) techniques for the treatment of patients 
with spontaneous pneumothorax. Although it has 
been suggested that VATS is ideally suited for the 
treatment of this problem and should be the proce- 
dure of choice, I' 2 no report has been published to 
document he efficacy of the procedure (e.g., free- 
dom from recurrent pneumothorax) in a large pa- 
tient cohort over a prolonged follow-up period. This 
study was undertaken to assess the safety and effi- 
cacy of a VATS approach for pneumothorax. 
Patients and methods 
All patients undergoing a VATS procedure for the 
treatment of spontaneous pneumothorax were identified 
through areview of records at St. Louis University Health 
Sciences Center, Medical City Hospital in Dallas, the 
University of Chicago Hospitals, Southern Illinois Univer- 
sity Medical Center at Springfield, Illinois, and the Uni- 
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versity of Pittsburgh Medical Center. Office charts and 
hospital records were reviewed to identify pertinent de- 
mographic data including age, race, and gender. Clinical 
data recorded included smoking history and duration (as 
recorded in pack-years), the laterality of pneumothorax 
(left, right, or bilateral), and the extent of pneumothorax 
(up to 25%, 26% to 50%, 51% to 75%, 76% to 100%, or 
tension pneumothorax) on the initial chest x-ray film. 
Operative data noted included indication for operation 
(uncomplicated first episode, recurrent ipsilateral pneu- 
mothorax, recurrent contralateral pneumothorax, persis- 
tent air leak, hemothorax, or tension pneumothorax), the 
number of blebs identified (none, one, or multiple), and 
the site of blebs (upper lobe, middle lobe, lower lobe, or 
multiple sites). The procedure performed was divided into 
the method of management of the pulmonary blebs and 
the method of pleurodesis if performed. Bleb manage- 
ment included identification and stapling of blebs, identi- 
fication and ablation of blebs by other methods (laser, 
ligature, or cautery), blind stapling of the apex when no 
bleb was identified, or pleurodesis only with no lung 
manipulation. The pleural procedures coded for included 
gauze abrasion, instillation of talc or other sclerotic 
chemicals, laser pleurodesis, partial pleurectomy, or no 
procedure. Operative complications and length of stay 
were also abstracted from the hospital charts. 
Follow-up was conducted uring clinic visits or tele- 
phone conversation with patients, their families, or their 
primary-care physicians. Inquiries were made regarding 
recurrence of pneumothorax nd new pulmonary symp- 
toms. 
Statistical nalysis was undertaken toidentify predictors 
of recurrent pneumothorax. An initial univariate analysis 
was performed with the use of Student's t test for contin- 
uous variables and a 2 × k contingency table for categoric 
variables. Parameters that were significant or marginally 
significant (p < 0.10) as predictors for recurrence were 
then entered into a stepwise linear regression analysis to 
identify independent predictors of recurrent pneumotho- 
tax. Actuarial freedom from recurrence was analyzed by 
means of a Berkson-Gage life-table model. 
Results 
One hundred thirteen consecutive patients were 
identified who had undergone a VATS procedure 
for the treatment of spontaneous pneumothorax at
the five participating institutions between February 
1991 and December 1993. The group comprised 68 
male and 45 female patients whose ages ranged 
from 15 to 92 years with a mean of 35.1 years. 
Ninety-five patients were white (84%), 15 were 
black (13%), and three (3%) were Hispanic or 
Oriental. Forty-seven patients (39.5%) had a history 
of smoking, with a mean of 12.6 pack-years among 
those who smoked. During the 119 hospitalizations, 
there were 52 left pneumothoraces (44%), 65 right 
(55%), and two bilateral pneumothoraces (2%). In 
11 cases the extent of pneumothorax could not be 
Table I. Operative indications, findings, and 
management 
No. % 
Surgical indications 
Ipsilateral recurrence 77 65 
Persistent air leak 24 20 
Contralateral recurrence 12 10 
Uncomplicated first episode 3 3 
Hemothorax 2 2 
Number of blebs 
None 11 9 
One 35 29 
Multiple 75 62 
Site of blebs 
Upper lobe 88 73 
Middle lobe 2 2 
Lower lobe 9 7 
Multiple sites 11 9 
Not stated 11 9 
Bleb management 
Bleb stapling 105 87 
Blind apical stapling 8 7 
Pleurodesis only 5 4 
Other bleb ablation 3 3 
(laser I, ligature 1, cautery 1) 
Pleural procedure 
Gauze abrasion 54 45 
Chemical pleurodesis 19 16 
Laser pleurodesis 16 13 
None 12 10 
Pleurectomy 10 8 
Talc pleurodesis 10 8 
determined from review of the records. The size of 
the pneumothorax in the remaining episodes was up 
to 25% in 40 (37%), 26% to 50% in 35 (32%), 51% 
to 75% in 13 (12%), 76% to 100% in 17 (16%), and 
tension pneumothorax was present in three in- 
stances (3%). 
The surgical indications, as well as the operative 
findings and management, are detailed in Table I. 
The most frequent indication for operative interven- 
tion was an ipsilateral recurrent pneumothorax, 
which was noted in 77 patients (65%). Four patients 
(3%) underwent VATS procedures for an uncom- 
plicated first episode of spontaneous pneumotllorax. 
In the majority of patients (62%) more than one 
bleb was visualized. However, in 11 patients (9%) no 
bleb or bulla could be identified. The most common 
site for blebs in the 110 procedures in which they 
were identified was the upper lobe (80%). Blebs 
were found in more than one lobe during 11 proce- 
dures (10%). 
Management of the lung in the 121 procedures 
performed included stapling (with or without exci- 
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Fig. 1. Actuarial freedom from recurrent pneumothorax 
after VATS procedure. Error bars indicate plus or minus 
one standard error. 
sion) of an identified bleb in 105 patients (87%). 
Three additional patients had blebs that were ab- 
lated by laser ablation, cautery, and ligature in one 
patient each. The final two patients in whom blebs 
were visualized underwent gauze abrasion pleuro- 
desis only. Management in the 11 patients with no 
identifiable bleb included pleurodesis by gauze abra- 
sion in eight patients, chemical instillation in two, 
and apical pleurectomy in one. Eight patients also 
underwent a "blind" stapling of the apex. 
Pleural procedures performed included gauze 
abrasion in 54 (45%), instillation of sclerotic hem- 
icals (tetracycline, doxycycline) in 19 (16%), talc 
instillation in 10 (8%), laser sclerosis in 16 (13.2%), 
and partial pleurectomy in 10 (8%). In 12 proce- 
dures (10%) no attempt at pleurodesis was under- 
taken. 
No operative deaths occurred and no procedure 
was converted to a thoracotomy atthe initial setting. 
Ten patients (8%) had an air leak lasting longer 
than 5 days. Two of these patients underwent second 
operative procedures (one VATS, one thoracot- 
omy) for definitive management of the air leaks. In 
no case did bleeding, empyema, ventilator depen- 
dence, stroke, or myocardial infarction occur. The 
postoperative stay ranged from 1 to 39 days with a 
median of 3 days and a mean of 4.3 _+ 4.5 days. 
Ninety-nine patients (84%) were discharged within 
5 days after the procedure. 
Patients were followed up between i and 34 
months with a mean follow-up of 13.1 months. 
Eleven patients (10%) were lost to follow-up. Re- 
current ipsilateral pneumothorax occurred after five 
of the 121 VATS procedures (4.1%). These oc- 
curred at 2, 4, 7, 13, and 52 weeks after the original 
VATS procedure. Actuarial freedom from recur- 
rence is depicted in Fig. 1. The recurrent pneumo- 
thoraces were managed in a variety of fashions. In 
one patient with a small (10%) loculated pneumo- 
thorax, observation only was undertaken. One pa- 
tient was treated only with a chest ube, two under- 
went repeat VATS procedures with pleurodesis, and 
the final patient underwent thoracotomy with partial 
pleurectomy. 
Twelve perioperative parameters were entered 
into univariate analysis to identify univariate predic- 
tors of recurrence. These included age, gender, race, 
smoking history, site of pneumothorax, severity of 
pneumothorax, operative indications, number of 
blebs, site of blebs, bleb ablation, method of pleu- 
rodesis, and the presence of a prolonged postoper- 
ative air leak. Only two parameters proved to be 
univariate predictors of recurrence: the number of 
identified blebs and ablation or nonablation of 
blebs. The recurrence rate after procedures inwhich 
multiple blebs were identified was 2.7% (2/75). 
When only one bleb was visualized it was 0% (0/35) 
and when no blebs were identified the incidence of 
recurrence was 27.3% (3/11) (p = 0.0002). In pro- 
cedures during which identified blebs were ablated 
there was a 1.8% (2/108) incidence of recurrence 
versus a 23% (3/13) incidence for those in which no 
bleb was identified and ablated (p = 0.003). Step- 
wise linear regression revealed that the performance 
of bleb ablation was a significant independent pre- 
dictor (p < 0.001). 
Discussion 
VATS has been received with an initial wave of 
enthusiasm that has led to the broad application of 
this technology to many thoracic arenas including 
diseases of the pericardium, pleura, lung, esopha- 
gus, thymus, and chest wall. 3 Now that several years 
of experience have been accumulated with this 
technique, it appears time to assess the early results 
for the routine use of VATS for thoracic surgical 
problems. 
Historically, operative intervention for recurrent 
spontaneous pneumothorax has been undertaken 
via standard posterolateral thoracotomy, anterior 
thoracotomy, sternotomy, and axillary minithora- 
cotomy. This last approach as become very popular 
and, before VATS, was probably the most com- 
monly used approach. Regardless of the approach, 
the operation performed was identification and ab- 
lation of pulmonary blebs via stapling or suture 
ligation. 
The point of greatest controversy arose over the 
need for and method of promoting adequate pleural 
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symphysis. Methods of pleurodesis have included 
mechanical abrasion with gauze, the instillation of 
chemical irritants (tetracycline, doxycycline, bleomy- 
cin), pleural irritation with a laser or cautery, and 
the instillation of talc. Recent experimental work by 
Bresticker and colleagues 4 compared the pleural 
adhesions promoted by the aforementioned meth- 
ods. Talc instillation and gauze abrasion proved 
effective and superior to laser, cautery, and tetracy- 
cline with regard to the quality and quantity of 
adhesions. Although equally effective, talc has been 
used less frequently than gauze abrasion because of 
fears of asbestos contamination and because of the 
excessive granulomatous inflammation it incites, 
which may make subsequent thoracotomy very dif- 
ficulty. Mechanical pleural abrasion with a sterile 
gauze sponge (or similar rough surface) has been 
long used and has a high rate of success as evidenced 
by a 0% to 5% recurrence rate. 5-9 This is currently 
our method of choice for pleurodesis with the VATS 
approach. 
Total pleurectomy is also effective for pleurodesis 
but has some disadvantages that have been addressed 
by "downsizing" the procedure to partial or apical 
pleurectomy. 1°-12 A report by Deslauriers and col- 
leagues 13 presented the results of over 400 transaxil- 
lary procedures in which apical pleurectomy was per- 
formed after ablation of pulmonary blebs. The rate of 
ipsilateral pneumothorax recurrence was slightly less 
than 1%, but three patients required reoperation for 
bleeding. This complication of pleurectomy has been 
reported by others and is one of the most frequent 
criticisms of the procedure, a2, a4,a5 One additional 
criticism of pleurectomy is that it will make a subse- 
quent horacotomy exceedingly difficult should any of 
these young patients require thoracic surgical interven- 
tion in future years, m' al 
Although the application of VATS for the treat- 
ment of pneumothorax has been relatively recent, 
rigid thoracoscopy has been used in the assessment 
and management of this disorder for three de- 
cades.a6, a7 The evolution from rigid thoracoscopy to 
VATS has occurred within the past 5 years, as Dur- 
ing this time the methods used for bleb ablation 
have also evolved from lasers 19 to cautery 2° or 
ligature 2a and, finally, to mechanical stapling. 22 With 
the introduction of endoscopic staplers, proponents 
of the VATS approach to spontaneous pneumotho- 
rax can assert that they are performing the same 
operation that they had used previously and have 
changed only the approach. 
Our experience documents that a VATS ap- 
proach is safe. The major complication encountered 
was an 8% incidence of prolonged air leak. This 
required a second procedure in two instances 
(1.7%), a reoperation rate not dissimilar to those in 
the reports of Brooks 6 (3.3%), Granke 9 (1.3%), 
Deslauriers 13 (1.0%), and their associates. Although 
our mean postoperative stay of 4.3 days is shorter 
than that reported for either a standard thoracot- 
omy or transaxillary approach, 4-9 the results may not 
be directly comparable because of differing patient 
populations and changes in discharge policies that 
have occurred over the past several years as a result 
of external pressures. However, even when com- 
pared with a very recent report of 14 highly selected 
patients (less than 30 years of age, no concomitant 
medical problems) treated via a transaxillary ap- 
proach, our mean postoperative stay compares fa- 
vorably (4.3 versus 5.1 days). 
Our recurrence rate of 4.1% falls within the 
accepted recurrence rate of patients treated for 
recurrent pneumothorax via an open approach. It is 
also similar to the incidence reported by Yamaguchi, 
and associates 23(2.7%) and Inderbitzi and Furrer 24 
(4.5%) in their early reports using VATS tech- 
niques. Our risk analysis did, however, reveal a 
worrisomely high recurrence rate in those patient in 
whom no bleb could be identified and ablated. It is 
in such patients that apical pleurectomy may be 
indicated. This could be performed at the same 
setting either via a VATS approach or via an axillary 
thoracotomy and would perhaps provide a more 
definitive pleural symphysis with a decreased likeli- 
hood of subsequent recurrence. We believe this 
approach should be strongly considered when no 
pulmonary disease can be visualized for the purpose 
of ablation. 
Unfortunately, spontaneous pneumothorax is a 
common problem and as such accounts for a con- 
siderable expenditure of money and resourcesY 
Much of the enthusiasm for VATS has come from 
the notion that minimally invasive surgery will 
shorten overall hospital stay, as well as lower total 
hospital cost and resource xpenditure. We did not 
specifically examine charges or costs in these pa- 
tients. This would have been exceedingly difficult 
given involvement of six institutions in different 
areas of the county. However, prior analyses of 
minimally invasive surgery both within the abdo.- 
men 26 and pertaining to open lung biopsy in the 
chest 27 have been undertaken in an attempt to 
identify relative charges and costs. Although hospi-- 
tal stay is generally shorter with the minimally 
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invasive technique, the increased expenditure asso- 
ciated with the technology (reusable and disposable 
equipment) and prolonged operative times have 
resulted in no net savings with regard to hospital 
charges. However, a full analysis of the cost-benefit 
relationship of VATS treatment of pneumothorax 
will need to take into account hospital charges, lost 
employment hours, and quality of life to provide 
valid answers regarding the appropriateness of a 
VATS approach. 
Our experience suggests that VATS is a viable 
alternative for the treatment of recurrent sponta- 
neous pneumothorax. We believe it is the treat- 
ment of choice when the decision is made for 
surgical intervention. The procedure is well toler- 
ated and allows for early discharge in 3 days or 
less in more than half the patients. The 4.1% 
recurrence rate is consistent with rates of recur- 
rence found when an open thoracotomy technique 
with gauze abrasion is used. As experience grows 
with the VATS technique, one might see a de- 
crease in the rate of recurrence as a result of a 
plateau in the learning curve. However, the cur- 
rent rate of recurrence appears acceptable, and 
we believe that VATS is an excellent initial ap- 
proach for this common problem. 
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Discussion 
Dr. Walter B. Cannon (Palo Alto, Calif.). VATS has 
now matured and become part of the daily armamentar- 
ium of thoracic surgeons throughout this country. There- 
fore, we have now reached the time to reflect and review 
its usefulness as a procedure in these times of costly 
medical care. As laparoscopy became the ideal therapeu- 
tic procedure for cholecystectomy, VATS has become the 
ideal procedure for bleb resection for spontaneous pneu- 
mothorax. With the advent of linear stapling devices and 
minicameras, the technical procedure became asy for the 
physician to perform and easy for the patient o tolerate. 
These authors have tried to prove that it is indeed the 
procedure of choice for patients who have spontaneous 
pneumothorax, and in my opinion they have done so. 
We at Stanford have tried over the past few years to 
devise ways of reducing the hospitalization time for these 
patients, and we believe that two adjuncts can be added to 
the procedure to reduce the hospital stay. The first is 
installation of 0.5% bupivacaine (Marcaine) into the chest 
tube at the completion of the procedure. This seems to 
reduce the pain in these patients in the early postoperative 
period. We have also begun to use much smaller chest 
tubes, usually No. 20, that we remove within 24 hours if 
there is no air leak and the lung is fully expanded. By using 
this method, we are able to discharge most patients with 
spontaneous pneumothorax the next day. 
We would agree with the authors about pleurodesis. We 
have not been happy with the argon beam coagulator or 
laser or even cautery and have resumed using either a 
sponge on a ring forceps or a small tonsil sponge on a 
holder. We do not like using talcum powder in young 
healthy patients because of the risk of long-term harmful 
effects. Limited pleurectomy has increased risks but may 
be necessary in some patients, as pointed out by the 
authors. For some reason we seem to see a large number 
of patients with cystic fibrosis who have a spontaneous 
pneumothorax. Resection of these blebs in these patients 
has yielded surprisingly good results. Because of the 
potential for lung transplantation we have not done any 
pleural procedures at all because the risk of recurrent 
spontaneous pneumothorax may be higher. However, our 
experience has not borne out that concern. These patients 
so far have had durable results. None of these patients has 
had lung transplantation, so we do not know how prob- 
lematic the pleural adhesions will be. 
Aggressive treatment of spontaneous pneumothorax at
the first event has occasionally been suggested, as in three 
patients whom Dr. Naunheim mentioned. We believe that 
75% of patients who have a spontaneous pneumothorax 
will never have another one. For those patients, therefore, 
we do not believe a bleb resection at the first event is 
appropriate. However, we agree with the authors that 
spontaneous pneumothorax and persistent air leak or 
bleeding are definite indications for the procedure. A1- 
though the cost of the procedure may be higher, if we 
assess the total cost to society, as the cardiac surgeons 
have done, these patients become productive citizens in 
less time. They are hospitalized for shorter periods and 
therefore the drain on other medical resources is less. I 
believe the procedure is the best one that we have to offer 
these patients in the setting of health care costs in this 
country. 
I would like to ask a couple of questions of Dr. 
Naunheim. Have you used ventilation scans to determine 
the location of an air leak, particularly in a patient who 
has a persistent air leak and may need another VATS or 
open procedure? Have you any tricks that you can use to 
find the air leak during a VATS procedure, which is 
difficult to do in comparison with doing an open proce- 
dure. 
Dr. Naunheim. We have not used ventilation scans, 
although that is an ingenious idea. In the majority of cases 
we depend on visual identification of the leaking bleb. The 
only trick we use is one well known to everybody: we direct 
our attention to the apex and the superior segment of the 
lower lobe. The vast majority of leaks will be there. We 
put the patient in the Trendelenburg position, instill 50 to 
75 ml of saline solution, and have the anesthesiologist 
insufflate the lung. The problem is that the operative view 
becomes omewhat obstructed at that point. To alleviate 
this visual obstruction, we visualize the lung lobe by lobe. 
We insert the scope through the midaxillary trocar site, 
and through a posterior or an anterior site we insert 
sponge sticks and try to compress the middle and lower 
lobes during insulttation and keep them compressed. Then 
once again we visualize the middle lobe, trying to keep the 
upper lobe and lower lobe compressed. Through a com- 
bination of compression of the lung and positive insuffta- 
tion of the lung, we attempt to find a leak just by following 
the bubbles. It does not always work. Sometimes we carl 
be fooled if we have to compress the lobe we are 
interested in such that it becomes atelectatic and the leak 
is missed. 
Dr. Marvin Pomerantz (Denver, Colo.). We have had six 
or seven patients with spontaneous pneumothoraces with- 
out apparent blebs. We have always resected the apex of 
the lung, and uniformly the pathologist finds cysts. In 
these cases, we use Marlex mesh (Bard Implants, Billerica, 
Mass.) on a ring forceps to get a better abrasion. We have 
been using this method for only 11/2 years, but we have not 
noted any recurrences. Do you have any experience that is 
similar? 
Dr. Naunheim. I must admit to being gratified when I 
find a bleb; however, when I cannot visualize such a lesion, 
I direct my therapy to the apex of the lung. I believe the 
odds are better than 50:50 that the bleb is in the apex even 
if I cannot find it. Thus, I staple the area and use gauze on 
a ring forceps to abrade the pleura. It may be that Marlex 
mesh is more abrasive and thus better. I cannot assert hat 
one is better than the other, but I do believe blind apical 
stapling makes some sense. Very little parenchyma is lost, 
and more than 50% of the time the bleb will be located in 
the apex whether it is identified or not. 
Dr. Robbin Cohen (Los Angeles, Calif.). I agree with Dr. 
Cannon that patients with uncomplicated first-time pneu- 
mothorax do not require surgical therapy. Would you 
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elaborate about the patients on whom you operated for 
primary uncomplicated first-time pneumothorax? 
From the age spread of your patients, I presume that 
some of them had primary spontaneous pneumothorax 
and that some of the older patients probably had second- 
ary pneumothoraces a a result of chronic obstructive 
pulmonary disease. In our experience, older patients with 
chronic obstructive pulmonary disease are sicker and our 
results are not quite as good. What approach do you use 
in those patients? Are your results in patients with sec- 
ondary pneumothorax similar to those obtained in 
younger patients with primary spontaneous pneumotho- 
rax? 
Dr. Naunheim. The results have been essentially equal 
except that the patients who are older, with chronic 
obstructive pulmonary disease, tend to have a more 
prolonged hospitalization. The incidence of air leak, 
which is the complication that generally prolongs the 
hospitalization time, was the same for patients older and 
younger than 40 years. However, it takes longer to get 
older patients up and moving. Patients who are in their 
70s and 80s cannot go home at 3 or 4 days. 
The patients operated on for first-time uncompli- 
cated pneumothorax were operated on early in the 
series. There was a great wave of enthusiasm with the 
advent of thoracoscopy, with suppositions being made 
thai the scalpel would become a relic of the past and 
thoracotomy would be of historical interest only. It was 
on the basis of this zeal and enthusiasm that we 
undertook a VATS procedure on three patients with 
primary pneumothorax who did not fit the classic 
indications. I completely agree, as do all my coauthors, 
that patients with primary uncomplicated first-time 
pneumothorax have only a 20% or 25% chance of ever 
requiring any intervention. Such patients have a 75% 
chance of living their life comfortably without three 
small incisions on their chest, and there is no reason for 
us to provide those for them. 
Dr. Paul Waters (Los Angeles, Calif.). I am not con- 
vinced that this is the procedure of choice for such 
patients. A 4- or 5-day mean hospital stay is the norm after 
regular transapical or transaxillary thoracotomy for the 
young patient with apical blebs. Do you have information 
on where the cost savings are? 
Dr. Naunheim. In the manuscript we explain why we did 
not try to do a cost analysis. The study encompasses six 
different institutions pread over a 3-year period with 
different billing systems at different hospitals. Also, no one 
really has any idea about actual cost; all we can gather 
information on is charges. 
The cost studies for thoracoscopy that I am aware of 
show no cost savings with regard to hospital charges. If 
VATS is going to offer an advantage, it is going to be with 
regard to patient pain, which we believe to be less with a 
VATS procedure. I do think the patients are going to be 
able to be discharged more quickly. We had patients as 
old as 92 years of age, and at least a quarter of our patients 
were older than 50 years of age. Many of these patients 
would have difficulty tolerating even a small thoracotomy. 
The vast majority of our patients under the age of 30 years 
are out of the hospital by 3 days. I have difficulty discharg- 
ing a patient in I or 2 days after an axillary thoracotomy or
any other kind of thoracotomy. I do believe we will 
eventually find that these patients return to work faster. I
do not think VATS is going to be any cheaper, but I do 
think the patients will have less discomfort and perhaps 
will lose less time from work. I have no data to substan- 
tiate these assumptions, however. 
